AIA Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
AIA Group's GILD Position: Q1 2026 in Review
AIA Group increased its Gilead Sciences (GILD) stake by 13% in Q1 2026, buying an estimated $521K and bringing the position to 31,834 shares worth $4.44M. The position accounts for 0.06% of the portfolio, ranked #169.
AIA Group first reported a position in GILD in Q4 2020 and has held it in 20 quarters since. The position peaked at $5.15M in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- AIA Group held 31,834 shares of Gilead Sciences worth $4.44M as of Q1 2026.
- AIA Group bought 3,721 Gilead Sciences shares in Q1 2026, an estimated $521K.
- Gilead Sciences made up 0.06% of AIA Group's portfolio in Q1 2026, its #169 holding.
- AIA Group first reported a position in Gilead Sciences in Q4 2020 and has held it in 20 quarters since.
- AIA Group's Gilead Sciences position peaked at $5.15M in Q3 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on AIA Group's 13F filing for Q1 2026, filed 6 May 2026.